keyboard_arrow_up

DiaSorin S.P.A (DIA) - Product Pipeline Analysis, 2014 Update

DiaSorinS.p.A. (DiaSorin) is a medical device company. It undertakes the development and manufacture of reagents pertaining to in-vitro diagnostics and systems that enable automatic diagnostic investigation. The company offers products grouped under two segments, namely, immunodiagnostics, and molecular diagnostics. Its key products offerings include radio immuno assays (RIA), enzyme linked immunosorbent assays (ELISA) and chemiluminescent immuno assays (CLIA) under immune diagnostics segment and extraction, amplification, and diagnostic products under molecular diagnostics segment. The company also develops and distributes immune reagent kits for clinical diagnostics and equipment that are to be used in combination with reagents, to facilitate automatic diagnostic investigation. The companys products address clinical areas such as infectious diseases, bone and mineral disorders, endocrinology, hypertension, oncology, gastrointestinal infections, autoimmune disorders, and neurological and cardiac diseases. DiaSorin Group operates through 23 companies and five branches in Europe, the US, Central and South America and Asia. The company is headquartered at Saluggia, Vercelli, Italy.

Browse Full Report With TOC: http://www.marketresearchreports.biz/analysis-details/diasorin-spa-dia-product-pipeline-analysis-2014-update

DiaSorin envisages on strengthening its position in the market by focusing on major product groups including CLIA product portfolio, Murex product line, Vitamin D market and molecular diagnostics market. It also strives to grow through strategic acquisitions and agreements.

 

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands. 

 

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

 

Scope:

 

·         The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

·         The report analyzes all pipeline products in development for the company DiaSorin S.p.A

·         The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

·         The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

·         The report provides detailed description of products in development, technical specification and functions

·         The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

·          

To Download Full Report with TOC: http://www.marketresearchreports.biz/sample/sample/207358

Reasons to Buy:

 

·         Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

·         Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

·         To formulate effective Research & Development strategies

·         Develop market-entry and market expansion strategies

·         Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

·         Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline 

·         Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

·         Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc

·         Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio


To Read Complete Report with TOC: http://www.marketresearchreports.biz/analysis/207358
 

Table of Content

Table of Contents 2
List of Tables 5
List of Figures 7
DiaSorin S.p.A Company Snapshot 8
DiaSorin S.p.A Company Overview 8
Key Information 8
DiaSorin S.p.A Pipeline Products and Clinical Trials Overview 9
DiaSorin S.p.A Pipeline Analysis Overview 11
Business Description 11
Key Facts 12
DiaSorin S.p.A - Major Products and Services 13
DiaSorin S.p.A Pipeline Products by Development Stage 15
DiaSorin S.p.A Pipeline Products Overview 18
AML-ETO 1 Assay 18
AML-ETO 1 Assay Product Overview 18
BCR-ABL p210 & p190 Assay 19
BCR-ABL p210 & p190 Assay Product Overview 19
C-Kit 816 Assay 20
C-Kit 816 Assay Product Overview 20
C-Kit 822 Assay 21
C-Kit 822 Assay Product Overview 21
CBFB-A Assay 22
CBFB-A Assay Product Overview 22

 

About Us

 

Marketresearchreports.biz is the most comprehensive collection of market research reports. Marketresearchreports.biz services are especially designed to save time and money of our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.


Contact US:

Office: United States

State Tower
90 State Street, Suite 700
Albany, NY 12207
United States


Toll Free: 866-997-4948
Tel: +1-518-618-1030
E: sales@marketresearchreports.biz